Prisinterval: $ 213 til $ 355
Subutex (buprenorphine) is a partial opioid agonist used for the treatment of opioid dependence. Available as sublingual tablets in 2mg and 8mg strengths, it helps reduce withdrawal symptoms and cravings in adults as part of a full treatment program including counseling and psychosocial support.
Subutex works by binding to opioid receptors in the brain, producing milder effects than full opioids like heroin or morphine. It is often preferred during the induction phase of treatment.
Key Benefits:
Subutex sublingual tablets contain buprenorphine hydrochloride, a partial agonist at the mu-opioid receptor. It is indicated for the treatment of opioid dependence and is preferred for induction in medication-assisted treatment (MAT).
How Subutex Works Buprenorphine partially activates opioid receptors, helping to suppress withdrawal symptoms and cravings while producing a ceiling effect on euphoria and respiratory depression. This makes it safer than full opioid agonists in overdose risk. It is administered sublingually (under the tongue) for optimal absorption, with effects starting within 30-60 minutes.
Main Uses:
Dosage and Administration Treatment should start when moderate objective signs of withdrawal appear. Typical induction: Day 1 up to 8mg, Day 2 up to 16mg, then maintenance dosing adjusted by the physician (usually 4-24mg daily). Tablets must dissolve completely under the tongue; do not swallow, chew, or crush. Dosing is once daily.
Quality and Formulation Subutex tablets are uncoated, oval, white, and debossed for identification (available in 2mg and 8mg buprenorphine free base). Manufactured under GMP standards (originally by Reckitt Benckiser; generics widely available).
Warnings and Precautions Subutex can cause serious side effects including respiratory depression (especially with benzodiazepines, alcohol, or other CNS depressants), dependence, and withdrawal if stopped abruptly. Common side effects: headache, nausea, sweating, constipation, insomnia, and pain. Not recommended in severe hepatic impairment or hypersensitivity to buprenorphine.
Monitor for misuse, as it is a controlled substance. Regular follow-up with a qualified healthcare provider is required. Avoid in pregnancy unless benefits outweigh risks (neonatal opioid withdrawal syndrome possible). Store securely and dispose of unused tablets properly.
Subutex remains an important option for opioid dependence treatment when used responsibly under medical supervision as part of a holistic recovery plan.
| Quantity | 100 Pills, 200 Pills |
|---|
English English 
Italian
German
Dutch
Spanish
Danish
French
Greek
Swedish
Finnish
Polish
Portuguese
Arabic